reference/6782265

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6782265

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, U.S. Gov't, Non-P.H.S.
issn	2379-3708
issueIdentifier	19
publicationName	JCI Insight
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e3c18600b59b2612497bf6b95256a2d6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e1e0c321d924981ed5773a8cf22bb1fd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8a84060532d8b9418fd17a2962a3d068 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cf5b9d5995507abc870f68cd20a978d7
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7774097ef01ba287de16cd9f6cab7e1f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7026e9beacda0ef83bb06fb83be2eae7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_601f5159c00f251aa0fcc2c304460d88 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_34217f7dc272c345facbc689e243b7cd http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2e9521e9b8197730787b0c02f1050984 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d62f51386142d8e7576b9b70134d6e59 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4c4f4a6c5972ec75e3fd979c7098e660
bibliographicCitation	Nyquist MD, Corella A, Mohamad O, Coleman I, Kaipainen A, Kuppers DA, Lucas JM, Paddison PJ, Plymate SR, Nelson PS, Mostaghel EA. Molecular determinants of response to high-dose androgen therapy in prostate cancer. JCI Insight. 2019 Oct 03;4(19). PMID: 31503550; PMCID: PMC6795499.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d4efe9a45560bc02f2f97de3a18118d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5685-7263 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfd621ec446b8ca3655adc8d7f77e822 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08bf03834d16555394b5f04e90c569f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67807299750ac710cc29ab9941f7d6a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e6f0e2f2d6020e3f1b9889c0d753f0f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5435-0335 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6832-3947 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9599cd4a6cb990cca2f7ea38fb1620ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec90f85d71572f6a7e9211d4380e3196 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b471c6069c6f2779c50bdec9bb4b855d
date	2019-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC6795499 https://pubmed.ncbi.nlm.nih.gov/31503550 https://doi.org/10.1172/jci.insight.129715
isPartOf	https://portal.issn.org/resource/ISSN/2379-3708 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/44864
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Molecular determinants of response to high-dose androgen therapy in prostate cancer
discusses	http://id.nlm.nih.gov/mesh/M000616464 http://id.nlm.nih.gov/mesh/M0446168 http://id.nlm.nih.gov/mesh/M0526868 http://id.nlm.nih.gov/mesh/M0001106
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D000728Q000494 http://id.nlm.nih.gov/mesh/D015972Q000187 http://id.nlm.nih.gov/mesh/D011471Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D056286Q000235 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D020869 http://id.nlm.nih.gov/mesh/D064113 http://id.nlm.nih.gov/mesh/D044767Q000235 http://id.nlm.nih.gov/mesh/D055786 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016158Q000235 http://id.nlm.nih.gov/mesh/D019008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983

Total number of triples: 60.